Hypertensive Disorders of Pregnancy Tied to Heart Damage 10 Years Later
FRIDAY, March 5, 2021 -- Women with a history of hypertensive disorders of pregnancy (HDP) and current hypertension show left ventricular remodeling a decade after delivery, according to a study published in the March 2 issue of the Journal of the American College of Cardiology.
Malamo E. Countouris, M.D., from the University of Pittsburgh Medical Center Heart and Vascular Institute, and colleagues assessed echocardiographic differences eight to 10 years after delivery among 102 women with normotensive pregnancies and 30 with HDP (21 with preeclampsia and nine with gestational hypertension).
The researchers found that compared with women with normotensive pregnancies, those with HDP history were more likely to have current hypertension (63 versus 26 percent). Women with HDP history also had higher interventricular septal thickness and relative wall thickness after adjusting for age, race, maternal vascular malperfusion lesions, body mass index, current hypertension, and hemoglobin A1c. Women with both HDP history and current hypertension had a higher proportion of left ventricular remodeling (79 percent) compared with all other groups (only HDP: 36.4 percent; only current hypertension: 46.2 percent; neither HDP nor hypertension: 38.2 percent).
"Women with both HDP history and current hypertension have pronounced differences in left ventricular structure and function a decade after pregnancy, warranting continued surveillance and targeted therapies for cardiovascular disease prevention," the authors write.
© 2021 HealthDay. All rights reserved.
Posted: March 2021
Read this next
TUESDAY, April 20, 2021 -- For U.S. collegiate athletes, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated with a low prevalence of cardiac...
MONDAY, April 19, 2021 -- Greater intake of red and processed meat is associated with worse imaging measures of cardiovascular health, including adverse ventricular remodeling,...
MONDAY, April 19, 2021 -- Within two to four months of starting gender-affirming hormone therapy (GAHT), transfeminine adults have lower mean systolic blood pressure and...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.